Drug-maker Cipla has appointed Sameer Goel as its country-head for India, effective from today. With experience of over 26 years, Goel comes from multinational drug major GlaxoSmithKline. He will report to Cipla Managing Director and Global Chief Executive Subhanu Saxena. Saxena too, who assumed office early last year, came from multinational Novartis. In his last assignment, Goel led a $0.4-billion business, based out of Johannesburg, with responsibility for 44 markets in sub-Saharan Africa.
Read the Hindu Business Line news report here.